We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence Tomography

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00873106
First Posted: April 1, 2009
Last Update Posted: September 6, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Birgit Sander, Glostrup University Hospital, Copenhagen
  Purpose
The purpose of the present study is to determine if the retinal thickness estimates of the Stratus OCT, the 3D OCT-1000, and the CirrusHD OCT are comparable in diabetic and in healthy individuals (OCT=Optical Coherence Tomography).

Condition Intervention
Healthy Diabetic Maculopathy Device: Optical coherence tomography

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence Tomography

Further study details as provided by Birgit Sander, Glostrup University Hospital, Copenhagen:

Primary Outcome Measures:
  • Retinal thickness and retinal volume from each OCT scan [ Time Frame: within 24 hours ]

Enrollment: 20
Study Start Date: February 2009
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Optical coherence tomography
    Stratus OCT: fast radial lines 3D OCT-1000: radial 2048 and 3D OCT Cirrus HD OCT: 3D OCT
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
A group of diabetic and healthy participants
Criteria

Inclusion Criteria:

  • diabetic retinopathy in the diabetic group
  • healthy retinas in the healthy group

Exclusion Criteria:

  • not able to cooperate
  • retinal disease other than macular oedema
  • severe media opacities (e.g. cataract)
  • prior macular laser photocoagulation except for large oedemas
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00873106


Locations
Denmark
Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Nordre Ringvej 57
Glostrup, Copenhagen, Denmark, DK-2600
Sponsors and Collaborators
Glostrup University Hospital, Copenhagen
Investigators
Principal Investigator: Dorte Nellemann Thornit, MD Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Nordre Ringvej 57, DK-2600 Glostrup, Denmark
  More Information

Responsible Party: Birgit Sander, ph.d, Glostrup University Hospital, Copenhagen
ClinicalTrials.gov Identifier: NCT00873106     History of Changes
Other Study ID Numbers: OCT comparison
First Submitted: March 18, 2009
First Posted: April 1, 2009
Last Update Posted: September 6, 2012
Last Verified: September 2012


To Top